1. Jumiarni W, Komalasari O. Inventory of Medicinal Plants as Utilized by Muna Tribe in Kota Wuna Settlement. Tradit Med J. 2017;22(1):45–56. 2. Yuliandra Y, Andalas U, Ismed F, Andalas U. Uji Toksisitas Subkronis
Ekstrak Etanol Tali Putri ( Cassytha filiformis L.) Terhadap Fungsi Ginjal Tikus. Sains Farm Klin. 2015;2(1):55–9.
3. Mythili S, Gajalakshmi S, Sathiavelu A, Sridharan TB. Pharmacological Activities of Cassytha filiformis : A Review. Asian J Plant Sci Res. 2011;1(1):77–83.
4. Dalimartha S. Atlas Tumbuhan Obat Indonesia. Jakarta: Puspa Suara; 2000.
5. Sathiavelu M, Arunachalam S. High Performance Thin Layer
Chromatography Profile of Cassytha filiformis. Asian Pac J Trop Biomed. 2012;1431–5.
6. Tsai T, Wang G, Lin L. Vasorelaxing Alkaloids and Flavonoids from Cassytha filiformis. J Nat Prod. 2008;71:289–91.
7. Raj B, Singh SDJ, John V, John S. Hepatoprotective and Antioxidant Activity Of Cassytha filiformis against CCl 4 Induced Hepatic Damage In
Rats. JOPR J Pharm Res. 2013;7(1):15–9. Available from:
http://dx.doi.org/10.1016/j.jopr.2013.01.011
8. Sahu ram kumar, Roy A, Saurabhkothiya, Maurya anup kumar, Kumar R.
Screening of Antipyretic and Analgesic Potential of Ethanol Extract of Cassytha filiformis Leaves. Res J Sci Technol. 2013;4(3):1–4.
9. Armenia, Yuliandra Y, Sattar MZA. Comparative Effectiveness of Defatted
Hypotensive Crude Extract, Ethyl Acetate and Butanolic Fractions of Cassytha filiformis L. on Different Models of Hypertensive Rats. World J Pharm Pharm Sci. 2014;3(12):200–8.
10. Yuliandra Y, A A, Arifin H. Antihypertensive And Antioxidant Activity of
Cassytha filiformis L. : A Correlative Study. Asian Pac J Trop Biomed. 2017;7(7):614–8.
11. Armenia, Alen Y, Ismed F, Yuliandra Y, Ananda R, Fitria. Blood Sugar Lowering Effectiveness of Cassytha filiformis Fractions on Diabetic Mice. Res J Pharm Biol Chem Sci. 2016;7(6):1142–7.
12. Quetin-leclercq J, Hoet S, Block S, Wautier MC, Stevigny C. Studies on Cassytha filiformis from Benin : Isolation , Biological Activities And Quantification of Aporphines. Proc Bioresour Drug Discov Dev. 2004;81– 107.
13. Adonu Cyril C, O EC, A AA, C UM. In Vitro Evaluation of Anti Bacterial
Activity of Extracts from Cassytha filiformis L. against Urogenital Clinical Gram Negative Bacteria. Res Artic Pharm Sci. 2013;3(2):99–107.
14. Govardhan P, Bandari J, Bandari S, Kumar KP. In Vitro Evaluation Of Effect Of Cassytha filiformis L . Extracts On Brain Neurotransmitters. J Sci. 2011;1(1):21–5.
15. RI KK. Peraturan Menteri Kesehatan Nomor 2406/ Menkes/ Per/ XII/ 2011
Kesehatan RI; 2011.
16. Group AS. Antimicrobial Resistance, Antibiotic Usage and Infection Control. Jakarta: Directorate General of Medical Care Ministry of Health Republic of Indonesia; 2005.
17. WHO. Promoting Rational Use Of Medicines: Core Components. Geneva:
World Health Organization; 2002.
18. Worthington RJ, Melander C. Overcoming Resistance to β-Lactam
Antibiotics. J Org Chem. 2013;78(9):4207–13.
19. Guala. Integrated Taxonomic Information System (ITIS). 2017 [cited 2018
Aug 31].Available from: https://www.itis.gov/servlet/SingleRpt/SingleRpt? search_topic=TSN&search_value=18173#null
20. CABI. International, Centre for Agriculture and Bioscience. Wallingford.
2018 [cited 2018 Aug 31]. Available from:
http://www.cabi.org/isc/datasheet/11493.
21. Dalimartha S. Atlas Tumbuhan Obat Indonesia. Jakarta: Penerbit Trubus Agriwidya; 2007.
22. Zambesiaca F. Flora Zambesiaca. Kew Databases. 2014 [cited 2018 Aug 31]. Available from: http://apps.kew.org/efloras/fz/families.html.
23. Plantuse. Plant Resources of South East Asia. 2016 [cited 2018 Aug 31].
Available from:
https://uses.plantnet-project.org/en/Cassytha_filiformis_(PROSEA).
24. Nelson SC. Cassytha filiformis. Coll Trop Agric Hum Resour. 2008;
25. Committee F of CE. Flora Of China St. Louis, Missouri and Cambridge, Massachusetts. USA: Missouri Botanical Garden and Harvard University; 2015.
26. Chang F, Chao Y, Teng C, Wu Y. Chemical Constituents from Cassytha filiformis. J Nat Prod. 1998;61(7):1–4.
27. Hercegovina. Uji Toksisitas Akut dan Tertunda Ekstrak Etanol Tali Putri (Cassytha filiformis L.) terhadap Mencit Putih Jantan. Universitas Andalas; 2014.
28. Stevigny, S B, Dehoffman, De-Pauw-Gillet, G L, V A, et al. Cytotoxic Aporphine Alkaloid from Cassytha filiformis. Planta Med. 2002;68:1042– 4.
29. Pubchem. Open Chemistry Database. National Center of Biotechnology Information. US National Library of Medicine.
30. Armenia, Gustinanda D, Salasa AN, Yuliandra Y, Friardi. Acute and Delayed Toxicity Study of Cassytha filiformis Defatted Ethanolic Extract. World. 2015;4(10):155–62.
31. Miftahuljannah. Pemeriksaan Reversibilitas Fungsi Hati akibat Efek Toksik dari Ekstrak Etanol Tumbuhan Tali Putri (Cassytha filiformis L.). Andalas University; 2016.
32. Agoes G. Teknologi Bahan Alam. Bandung: ITB Press; 2007.
33. Depkes R. Kriteria dan Tata Laksana Pendaftaran Obat Tradisional, Obat Herbal Terstandar dan Fitofarmaka. Jakarta: Departemen Kesehatan Republik Indonesia; 2014.
Padang: Universitas Baiturahmah; 1988.
35. Harti A. Mikrobiologi Kesehatan. Yogyakarta: Cv. Andi Offset; 2015.
36. Radji M. Buku Ajar Mikrobiologi: Panduan Mahasiswa Farmasi & Kedokteran. Jakarta: EGC; 2011.
37. Ullah H, Ali S. Classification of Antibacterial Agents and Their Functions. 2017.
38. Sarpong EM, Miller GE. Narrow and Broad Spectrum Antibiotic Use
among U . S . Children. Health Serv Res. 2014;830–46.
39. Tjay T, Rahardja K. Obat Penting: Khasiat, Penggunaan dan Efek-Efek
Sampingnya. Jakarta: Gramedia; 2007.
40. Lin J, Nishino K, Roberts MC, Tolmasky M, Aminov RI, Zhang L.
Mechanisms of Antibiotic Resistance. Front Microbiol. 2015;6:1–3.
41. Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2016;1–10. Available from: http://dx.doi.org/10.1016/j.jiph.2016.08.007
42. Singh S, Bacon A, Young D, Couch K. In vitro 24 Hour Time Kill Studies
Of Vancomycin And Linezolid In Combination Versus Methicillin
Resistant Staphylococcus aureus. Antimicroba Agents Chemother. 2009;53(10):4495–7.
43. Pratiwi S. Mikrobiologi Farmasi. Jakarta: Erlangga; 2008.
44. Balouiri M, Sadiki M, Ibnsouda SK. Methods for In Vitro Evaluating Antimicrobial Activity : A Review. J Pharm Anal. 2016;6(2):71–9. Available from: http://dx.doi.org/10.1016/j.jpha.2015.11.005
45. Behzad MN, Akhi MT, Alizadeh M, Saleh P, Jafarzadeh S, Navi ZS, et al.
Staphylococcus aureus : Resistance Pattern And Risk Factors. Anal Res Clin Med. 2015;3(1):43–50.
46. Chatterjee M, Anju CP, Biswas L, Kumar VA, Mohan CG, Biswas R. International Journal of Medical Microbiology Antibiotic resistance in Pseudomonas aeruginosa and Alternative Therapeutic Options. Int J Med
Microbiol.2016;306(1):48–58. Available from:
http://dx.doi.org/10.1016/j.ijmm.2015.11.004
47. Bsp DMS, Frcpc KL, Pitout J, Dalton B, Pharmd B, Frcpc HR, et al. Utilization of Colistin for Treatment of Multidrug-resistant Pseudomonas aeruginosa. Can J Infect Dis Med Microbiol. 2008;19(6):413–8.
48. Jang J, Hur H, Sadowsky MJ, Byappanahalli MN, Yan T, Ishii S.
Environmental Escherichia coli : Ecology And Public Health Implications A Review. J Appl Microbiol. 2017;123(3):570–81.
49. Vranic SM, Uzunovic A. Antimicrobial Resistance of Escherichia coli Strains Isolated from Urine at Outpatient Population: a Single Laboratory Experience . Materia Socio Medica. 2016;28(2):121–4.
50. Morril HJ, Morton JB, Caffrey AR, Jiang L, Dosa D, Mermel LA, et al. Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System. Antimicrob Agents Chemother. 2017;61(5):1–5.
51. Anderson, Elisabeth T. Buku Ajar Keperawatan Komunitas : Teori dan
Praktek. Jakarta: EGC; 2007.
Molecular Medical Microbiology,. Elsevier Ltd; 2015. 1547-1564 p. Available from: http://dx.doi.org/10.1016/B978-0-12-397169-2.00087-1 53. Lowenstine LJ, Osborn KG. Respiratory System Diseases of Nonhuman
Primates. Second Edition. Nonhuman Primates in Biomedical Research.
Elsevier Inc.; 2012. 413-481 p. Available from:
http://dx.doi.org/10.1016/B978-0-12-381366-4.00009-2
54. Bi W, Liu H, Dunstan RA, Li B, Torres VVL, Cao J, et al. Extensively Drug-Resistant Klebsiella pneumoniae Causing Nosocomial Bloodstream Infections in China : Molecular Investigation of Antibiotic Resistance Determinants, Informing Therapy and Clinical Outcomes. Front Microbiol. 2017;8.
55. Adamo R, Margarit I. Fighting Antibiotic Resistant Klebsiella pneumoniae with Sweet Immune Targets. Am Soc Microbiol. 2018;9(3):1–4.
56. Piperaki ET, Syrogiannopoulos GA, Tzouvelekis LS, Daikos GL.
Klebsiella pneumoniae : Virulence , Biofilm and Antimicrobial Resistance. Pediatr Infect Dis J. 2017;36(10):1002–5.
57. Haque N, Hossain M, Bilkis L, Musa A, Mahamud C, Barie M. Antibiotic
Susceptibility Pattern of Staphylococcus epidermidis. Mymensingh Med J. 2009;18(2):142–7.
58. Chessa D, Ganau G, Spiga L, Bulla A, Mazzarello V. Staphylococcus aureus and Staphylococcus epidermidis Virulence Strains as Causative Agents of Persistent Infections in Breast Implants. Implant Infect are Emerg as an Important Heal Probl. 2016;1–15.
59. Azimi L, Alaghebandan R, Asadian M, Alinejad F, Rastegar Lari A. Multidrug resistant Pseudomonas aeruginosa and Klebsiella pneumoniae circulation in a burn hospital , Zirkulation multiresistenter Pseudomonas aeruginosa and Klebsiella pneumoniae. GMS Hyg Infect Control. 2019;14:1–5.
60. Luwasola Olorunmola F, Kolawole DO, Lamikanra A. Antibiotic
Resistance and Virulence Properties in Escherichia coli Strains From Case of Urinary Tract Infections. Africa J Infect Dis. 2013;7(1):1–7.
61. Campoccia D, Montanaro L, Baldassarri L, An Y, Arciola C. Antibiotic resistance in Staphylococcus aureus and Staphylococcus epidermidis Clinical Isolates From Implant Orthopedic Infections. Int J Artif Organs. 2005;28(11):86–91.
62. Khare A, Kothari S, Misra V. IJBCP International Journal of Basic & Clinical Pharmacology Original Research Article Incidence and sensitivity pattern of Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa in a Tertiary Care Hospital. Int J Basic Clin Pharmacol. 2017;6(2):329–33.
63. Smith AC, Hussey MA. Gram Stain Protocols. Am Soc Microbiol. 2005;1–
9.
64. Th Y, Nasir IA, Usman Y. Laboratory Perspective of Gram Staining and its
Signifi cance in Investigations of Infectious Diseases. African J Med. 2014;1(4):3–6.
Sunderland: Sinaeur Associates; 2001.
66. Dolch ME, Janitza S, Boulesteix AL, Lichtenauer CG, Praun S, Denzer W,
et al. Gram negative and positive bacteria differentiation in blood culture samples by headspace volatile compound analysis. J Biol Res. 2016;23(3):1–8.
67. Beveridge TJ. Use of the Gram stain in microbiology. Biotech
Histocemhistry. 2001;76(3):111–8.
68. Hermawan A, Eliyani H, Tyasningsih W. Artikel Ilmiah Pengaruh Ekstrak
Daun Sirih ( Piper betle L .) terhadap Pertumbuhan Staphylococcus aureus dan Escherichia coli dengan Metode Difusi Disk. 2007;
69. Jorgensen JH, Ferraro MJ. Antimicrobial Susceptibility Testing : A Review of General Principles and Contemporary Practices and The Rationale for Performing. Med Microbiol. 2009;49:1749–55.
70. Institute C and LS. M100-S23 Performance Standards for Antimicrobial Susceptibility Testing; Twenty Third Informational Supplement. USA: Clinical and Laboratory Standard Institute; 2013.
71. Gashe F, Mulisa E, Mekonnen M, Zeleke G. Antimicrobial Resistance Profile of Different Clinical Isolates against Third Generation Cephalosporins. J Pharm. 2018;1–7.
72. Manchi H, Kudagi BL, Buchineni M, Jithendra K. Original Research Article Cephalosporin Resistance Pattern In A Tertiary Care Hospital An Observation Study. Int J Curr Microbiol Apllied Sci. 2014;3(12):718–25.
73. Adonu C., Enwa F., T G, Anie CO, Esimone CO, A AA. Evaluation Of The
Combined Effects Of Cassytha filiformis and Cleistopholis Patens Against Some Clinical Isolates Of Staphylococcus aureus. World J Pharm Pharm Sci. 2013;2(6):4249–58.
74. Li X, Wang L, Zhang X, Yang Y, Gong W, Xu B, et al. Evaluation of Meropenem Regimens Suppressing Emergence of Resistance in Acinetobacter baumannii with Human Simulated Exposure in an In Vitro Intravenous Infusion Hollow Fiber Infection. Antimicrob Agents Chemother. 2014;58(11):6773–81.
75. Luyt CE, Aubry A, Lu Q, Micaelo M, Brechot N, Brossier F, et al. Pseudomonas aeruginosa Ventilator Associated Pneumonia. Antimicroba Agents Chemother. 2014;58(3):1372–80.
76. Capriotti K, Capriotti JA. Dimethyl Sulfoxide. J Clin Aesthetic
Dermatology. 2012;5(9):24–6.
77. Kesehatan D. Inventaris Obat Indonesia Jilid I Badan Penelitian dan Pengembangan Kesehatan. Jakarta: Departemen Kesehatan Republik Indonesia; 1988.
78. Coculescu B. Antimicrobial Resistance Induced by Genetic Changes. J Med Life. 2009;2(2):114–23.
79. Harborne J. Metode Fitokimia Penuntun Cara Modern Menganalisa
Tumbuhan. Edisi Kedua. Padmawinata K, Soediro I, editors. Bandung: ITB; 1984.
80. Naim R. Senyawa Antimikroda dari Tanaman. Dosen FKH dan
81. Robinson T. Kandungan Organik Tumbuhan Tingkat Tinggi. Bandung: Institut Teknologi Bandung; 1995.
82. Heinrich M. Farmakognosi dan Fitoterapi. Buku Kedokteran Indonesia. Jakarta; 2009.
83. Sundari D, Kosasih P, Ruslan K. Analisis Fitokimia Ekstrak Etanol Daging Buah Pare (Momordica charantia L.). Institut Teknologi Bandung; 1996.
84. Dyozem JP, Hamamoto H, Ngameni B, Ngadjui BT, Sekimizu K. Antimicrobial Action Mechanism of Flavonoids from Dorstenia species. Drug Discov Ther. 2013;7(2):66–72.
85. Volk WA, F WM. Mikrobiologi Dasar. Edisi IV. S A, editor. Jakarta: Erlangga; 1990.
86. Pelczar MJ, Chan ECS. Dasar-Dasar Mikrobiologi. 1st ed. Jakarta: Universitas Indonesia; 1986.
87. Gunawan IW, Bawa IG, Sutrisnayanti N. Isolasi dan Identifikasi Senyawa Terpenoid Yang Aktif Antibakteri Pada Herba Meniran (Phyllanthus niruri Linn). J Kim. 2008;2(1):31–9.
88. Cowan M. Plants Products as Antimicrobial Agents. Clin
Microbiol Rev. 1999;12(4):564–82.
89. Dewi F. Aktivitas Antibakteri Ekstrak Etanol Buah Mengkudu (Morinda citrifolia Linnaeus) Terhadap Bakteri Pembusuk Daging Segar. Universitas Sebelas Maret; 2010.
90. Silhavy TJ, Kahne D, Walker S. The Bacterial Cell Envelope. Cold Spring Harb Perspect Biol. 2010;1–16.
